All News

The Supreme Court announced earlier this month their intention to investigate a multibillion-dollar dispute between the pharmaceutical industry and federal antitrust enforcers. The practice in question is commonly referred to as the pay-for-delay model, whereby brand-name drug manufacturers compensate other manufacturers to hold off on selling generic versions of their drug.

Despite rejections of multiples states' pleas for partial expansion of Medicaid, President Obama has given the green light for health insurance marketplaces in 6 states.